Bangalore, India – Biotech innovator Loopworm has raised $3.25 million in a funding round led by WaterBridge Ventures and Enrission India Capital, with participation from Claris Capital, Vinay Mittal, Rohit Chawla, and Keshav Damani. The investment will drive the commercialization of Loopworm’s proprietary silkworm-based recombinant protein production platform.
After three years of R&D, Loopworm has developed a novel method that uses silkworms as bio-factories to produce high-yield, high-quality recombinant proteins. This technology offers a sustainable alternative to traditional bioreactor-based systems and has wide-ranging applications in diagnostics, animal health, and industrial biotechnology.
The funding will support the setup of a dedicated commercial facility and help bring Loopworm’s protein solutions to market. It will also fuel the company’s international expansion in the animal and pet nutrition sectors.
With this milestone, Loopworm is set to contribute significantly to India’s bio-economy goals while addressing global needs for scalable and affordable protein manufacturing.
About Loopworm:
Founded in 2019 by IIT-Roorkee alumni, Loopworm is a Bengaluru-based biotech startup leveraging insect bioscience to develop sustainable protein solutions. The company transforms silkworms into bio-factories for producing high-yield recombinant proteins and also operates one of India’s largest insect-processing facilities for animal and pet nutrition. With a strong focus on circular economy and biotechnology, Loopworm aims to redefine nutrition, health, and wellness through eco-friendly innovations.